Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn Winter

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Urologic Oncology|March 31, 2019
An investigator's introduction to statistical considerations in clinical trialsKathryn Winter, Stephanie L Pugh
JAMA Oncology|March 30, 2018
Questions About a Clinical Trial Evaluating the Addition of Cetuximab to Definitive Chemoradiation Therapy With Paclitaxel and Cisplatin for Patients With Esophageal Cancer-ReplyMohan Suntharalingam, Kathryn Winter, David Ilson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31Colleen A Lawton, Kathryn Winter, David Grignon, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancerKathryn Greven, Kathryn Winter, Kelly Underhill, et al.
Gynecologic Oncology|March 21, 2006
Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancerKathryn Greven, Kathryn Winter, Kelly Underhill, et al.
Head & Neck|December 25, 2008
Quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90-03: phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinomaAndre A Konski, Kathryn Winter, Bernard F Cole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012Mohammed Mohiuddin, Kathryn Winter, Edith Mitchell, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2007
Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116William Small, Kathryn Winter, Charles Levenback, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2002
Long-term follow-up of RTOG 88-05: twice-daily external irradiation with brachytherapy for carcinoma of the cervixPerry Grigsby, Kathryn Winter, Ritsuko Komaki, et al.
Brachytherapy|September 18, 2013
RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma--year-5 toxicity and cosmesisRachel Rabinovitch, Kathryn Winter, Robert Kuske, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Urologic Oncology|March 31, 2019
An investigator's introduction to statistical considerations in clinical trialsKathryn Winter, Stephanie L Pugh
JAMA Oncology|March 30, 2018
Questions About a Clinical Trial Evaluating the Addition of Cetuximab to Definitive Chemoradiation Therapy With Paclitaxel and Cisplatin for Patients With Esophageal Cancer-ReplyMohan Suntharalingam, Kathryn Winter, David Ilson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31Colleen A Lawton, Kathryn Winter, David Grignon, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancerKathryn Greven, Kathryn Winter, Kelly Underhill, et al.
Gynecologic Oncology|March 21, 2006
Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancerKathryn Greven, Kathryn Winter, Kelly Underhill, et al.
Head & Neck|December 25, 2008
Quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90-03: phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinomaAndre A Konski, Kathryn Winter, Bernard F Cole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012Mohammed Mohiuddin, Kathryn Winter, Edith Mitchell, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2007
Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116William Small, Kathryn Winter, Charles Levenback, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2002
Long-term follow-up of RTOG 88-05: twice-daily external irradiation with brachytherapy for carcinoma of the cervixPerry Grigsby, Kathryn Winter, Ritsuko Komaki, et al.
Brachytherapy|September 18, 2013
RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma--year-5 toxicity and cosmesisRachel Rabinovitch, Kathryn Winter, Robert Kuske, et al.
Pageof 8